Obstetrics and gynecology
-
Obstetrics and gynecology · May 2002
Randomized Controlled Trial Clinical TrialAutologous blood transfusion in radical hysterectomy with and without erythropoietin therapy.
To investigate whether preoperative treatment with erythropoietin facilitates the collection of a sufficient amount of autologous blood in a short period of time. ⋯ Most women can predeposit three units of whole blood in only 2 weeks without obtaining severe anemia. By treating women with erythropoietin, one out of seven can be prevented from a hemoglobin level below the 100 g/L limit for donation.
-
Obstetrics and gynecology · May 2002
Randomized Controlled Trial Clinical TrialA randomized controlled trial of early oral analgesia in gynecologic oncology patients undergoing intra-abdominal surgery.
To evaluate the safety and efficacy of early oral analgesia after intra-abdominal surgery in gynecologic oncology patients. ⋯ Early oral analgesia in gynecologic oncology patients undergoing intra-abdominal surgery is safe and efficacious.
-
Obstetrics and gynecology · May 2002
Case ReportsA hair tourniquet resulting in strangulation and amputation of the clitoris.
Hair tourniquet syndrome involves fibers of hair or thread wrapped around an appendage producing tissue necrosis. Appendages commonly involved include the toe, finger, and penis. We report a hair tourniquet resulting in amputation of the clitoris. ⋯ We report a case of a clitoral hair tourniquet syndrome leading to autoamputation of the clitoris. A high index of suspicion for this condition is important because of the potential consequences of delayed treatment.
-
Obstetrics and gynecology · May 2002
Case ReportsFactor VII deficiency in pregnancy treated with recombinant factor VIIa.
Factor VII deficiency is an autosomal recessive bleeding disorder with an incidence of one in 500,000. Few cases have been reported in pregnancy, and only two patients were treated with recombinant factor VIIa. In the past, fresh frozen plasma or factor VII concentrate has been the conventional treatment for this disorder. ⋯ Given the inherent risks of transmission of human immunodeficiency virus and hepatitis with blood products, recombinant factor VIIa treatment is an alternative that is safe and effective during labor, delivery, and the puerperium.
-
Obstetrics and gynecology · May 2002
Practice Guideline GuidelineACOG practice bulletin. Diagnosis and treatment of cervical carcinomas, number 35, May 2002.
Invasive cervical carcinoma, once the most common reporductive-tract cancer in the United States, has recently fallen to the rank of third most common. Globally, cervical cancer is a major health problem, with a yearly incidence of 371,000 cases and an annual death rate of 190,000 (1). ⋯ This document will describe staging criteria and treatment for cervical carcinoma. For practical purposes, it will focus on the squamous and adenocarcinoma histologies only.